Harrow Health, Inc. 8.625% Senior Notes due 2026 (HROWL) NASDAQ

25.61

+0.0478(+0.19%)

Updated at October 10 04:00PM

Currency In USD

Valuation

Market Cap1.2B
Enterprise Value1.38B
P/E Ratio-180.43
PEG Ratio-3.44
Price/Sales Ratio8.16
Price/Book Ratio37.17
Enterprise/Revenue8.94
Enterprise/EBITDA63.42

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.04
Operating Margin0.06

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.18

Income Statement

Revenue199.61M
Revenue/Share6.19
Gross Profit150.37M
EBITDA22.13M
Net Income-17.48M
Diluted EPS-0.49

Balance Sheet

Total Cash74.29M
Total Cash/Share1.44
Total Debt251.87M
Total Debt/Equity4.66
Current Ratio0.62
Book Value Per Share1.34

Price History

52-Week Change1.43
52-Week High25.72
52-Week Low25
Moving Average 50 Days25.48
Moving Average 200 Days25.35

Statistics

Average Volume16,250
Shares Outstanding53.36M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A